Abstract

A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal, and at least one antibody for the cancer. A method of treating cancer in a mammal is also disclosed. The method comprises administering a suitable orally administered glucan and at least one antibody for the treatment of cancer to the mammal. In addition a composition for delivery of peptide, protein, RNA, DNA or plasmid comprising effective amount of a beta-glucan is disclosed.


Claims
Download PDF
Document Preview
Document History
  • Publication: Mar 15, 2011
  • Application: Jan 17, 2006
    US US 33476306 A
  • Priority: Jan 17, 2006
    US US 33476306 A
  • Priority: Aug 31, 2005
    US US 21804405 A
  • Priority: Jul 16, 2004
    US US 2004/0023099 W
  • Priority: Jul 16, 2003
    US US 62102703 A
  • Priority: Jan 15, 2002
    US US 0201276 W
  • Priority: Jan 16, 2001
    US US 26191101 P

Sign in to the Lens